Enovis Corp (ENOV)

Currency in USD
25.42
+3.10(+13.89%)
Closed·
25.85+0.43(+1.69%)
·
Unusual trading volume
ENOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.6225.86
52 wk Range
21.0040.70
Key Statistics
Prev. Close
22.32
Open
22.62
Day's Range
22.62-25.86
52 wk Range
21-40.7
Volume
2.7M
Average Volume (3m)
1.04M
1-Year Change
-33.3158%
Book Value / Share
35.35
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENOV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44.73
Upside
+75.95%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Enovis Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Enovis Corp Earnings Call Summary for Q4/2025

  • Enovis reported Q4 EPS of $0.95, beating forecasts by 15.85%, while revenue of $575.7M missed estimates by 1.54%; stock surged 8.47%.
  • Full-year 2025 revenue reached $2.2B with 7% YoY growth; gross margins expanded 170 bps to 61% driven by operational efficiency.
  • Reconstruction segment delivered 8% organic growth outpacing market; Prevention & Recovery segment accelerated to 4% organic growth.
  • Company projects FY2026 EPS of $3.51; plans to leverage innovation pipeline and product launches to sustain growth momentum.
  • Management absorbed $15M in tariff costs during 2025; implementing productivity initiatives to offset supply chain and currency headwinds.
Last Updated: 26/02/2026, 14:46
Read Full Transcript

Compare ENOV to Peers and Sector

Metrics to compare
ENOV
Peers
Sector
Relationship
P/E Ratio
−1.1x10.2x−0.6x
PEG Ratio
0.000.000.00
Price/Book
0.7x3.4x2.6x
Price / LTM Sales
0.7x2.5x3.3x
Upside (Analyst Target)
79.0%36.7%44.5%
Fair Value Upside
Unlock5.6%5.2%Unlock

Analyst Ratings

11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 44.73
(+75.95% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Needham
Buy52.00+104.56%49.00Maintain26/02/2026
BTIG
Buy41.00+61.29%-New Coverage06/01/2026
UBS
Buy50.00+96.70%57.00Maintain05/01/2026
Canaccord Genuity
Buy50.00+96.70%58.00Maintain17/12/2025
Freedom Capital Markets
Buy45.00+77.03%-New Coverage17/12/2025

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
0.95 / 0.82
Revenue / Forecast
575.70M / 584.71M
EPS Revisions
Last 90 days

Enovis (ENOV) Income Statement & Profits

People Also Watch

27.90
MAN
+8.01%
90.37
CHDN
-6.00%
107.20
EHC
+1.01%
6.80
CERT
+3.19%
27.26
RAMP
+3.49%

FAQ

What Is the Enovis (ENOV) Share Price Today?

The Enovis stock price today is 25.42 USD.

What Stock Exchange Does Enovis (ENOV) Trade On?

Enovis is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Enovis?

The stock symbol (also called a 'ticker') for Enovis is "ENOV."

What Is the Current Enovis Market Cap?

As of today, Enovis market cap is 1.45B USD.

What Is Enovis's (ENOV) Earnings Per Share (TTM)?

The Enovis EPS is currently -20.75 (Trailing Twelve Months).

When Is the Next Enovis Earnings Date?

Enovis's next earnings report will be released on 13/05/2026.

Is ENOV a Buy or Sell From a Technical Analyst Perspective?

Based on today's Enovis moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Enovis Stock Split?

Enovis has split 1 times. (See the ENOV stock split history page for full effective split date and price information.)

How Many Employees Does Enovis Have?

Enovis has 7367 employees.

What is the current trading status of Enovis (ENOV)?

As of 27/02/2026, Enovis (ENOV) is trading at a price of 25.42 USD, with a previous close of 22.32 USD. The stock has fluctuated within a day range of 22.62 USD to 25.86 USD, while its 52-week range spans from 21.00 USD to 40.70 USD.

What Is Enovis (ENOV) Price Target According to Analysts?

The average 12-month price target for Enovis is 44.73 USD, with a high estimate of 55 USD and a low estimate of 33 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +75.95% Upside potential.

What Is the ENOV Premarket Price?

ENOV's last pre-market stock price is 22.50 USD. The pre-market share volume is 4,920.00, and the stock has decreased by 0.18, or 0.81%.

What Is the ENOV After Hours Price?

ENOV's last after hours stock price is 25.85 USD, the stock has decreased by 0.43, or 1.69%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.